Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Repligen share price today

Repligen Corporation · RGEN · Healthcare · Medical Instruments & Supplies · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Repligen share price: $178.20 at the close on 4 November 2026, +24.8% in a year.

Getting worseBusiness trend from the last 12 quarters
$178.20Price +24.8% in a year
246.9×P/E higher than 65% of the last 4.6 years
$204 MRevenue (Jun 2026) +11.9% on a year ago
$5.0 MProfit (Jun 2026) −66.3% on a year ago
9.3%Operating margin +4.8 points on a year ago
2%ROE FY25
−4.8%ROIC against a 9.3% cost of capital: −14.1 points

Repligen Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work.

The price has been rising for 15 weeks, and the P/E is higher than 65% of its own last 4.6 years. Over the last four quarters, results have been improving, with profit −66.3% on a year earlier, and 149% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.

What is the Repligen share price today?

Repligen Corporation's share price was $178.20 at the close on 4 November 2026. It has been rising for 15 weeks. That is 22.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between $103 and $190, and at that close it sat 87% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Repligen Corporation is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 22 weeks in a row.

1Y

Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.

  • Price $178.20
  • 50-day avg $177.75
  • 200-day avg $144.97
Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$149.06$135.46$135.03
7 Nov 2025$142.82$137.92$134.56
14 Nov 2025$152.37$141.04$134.13
21 Nov 2025$162.51$144.66$133.95
28 Nov 2025$171.02$148.74$134.33
5 Dec 2025$164.98$152.95$134.72
12 Dec 2025$157.39$155.55$134.72
19 Dec 2025$162.38$156.57$134.76
26 Dec 2025$166.21$158.01$135.15
2 Jan 2026$164.35$158.85$135.50
9 Jan 2026$166.82$159.70$136.17
16 Jan 2026$162.02$161.35$136.95
23 Jan 2026$162.33$163.03$137.86
30 Jan 2026$149.37$163.62$138.83
6 Feb 2026$142.18$162.36$139.18
13 Feb 2026$136.44$159.36$139.09
20 Feb 2026$135.68$157.12$139.03
27 Feb 2026$128.73$154.33$139.14
6 Mar 2026$119.99$150.70$139.06
13 Mar 2026$114.20$146.02$139.00
20 Mar 2026$113.88$140.91$138.89
27 Mar 2026$110.12$135.72$138.52
2 Apr 2026$117.78$131.89$138.26
10 Apr 2026$120.10$127.38$138.22
17 Apr 2026$131.21$125.20$138.33
24 Apr 2026$117.60$123.45$138.24
1 May 2026$117.20$121.54$138.05
8 May 2026$123.46$120.50$138.21
15 May 2026$102.87$118.81$137.87
22 May 2026$115.06$117.81$137.73
29 May 2026$123.95$117.99$137.82
5 Jun 2026$122.31$118.72$137.76
12 Jun 2026$130.59$120.28$137.97
18 Jun 2026$132.02$121.44$138.19
26 Jun 2026$147.01$122.61$138.61
2 Jul 2026$142.40$123.24$139.05
10 Jul 2026$144.24$125.54$139.52
17 Jul 2026$147.25$128.41$140.10
24 Jul 2026$131.96$130.15$139.95
31 Jul 2026$141.01$133.68$139.76
7 Aug 2026$163.90$137.88$139.86
14 Aug 2026$166.83$142.19$139.96
21 Aug 2026$181.13$146.95$140.61
28 Aug 2026$176.27$151.78$141.49
4 Sep 2026$167.60$155.63$141.97
11 Sep 2026$165.18$157.71$142.17
18 Sep 2026$176.89$161.03$142.28
25 Sep 2026$189.68$165.02$142.83
2 Oct 2026$181.70$169.67$143.51
9 Oct 2026$173.88$173.19$143.85
16 Oct 2026$175.42$175.78$144.13
23 Oct 2026$176.93$177.10$144.39
30 Oct 2026$176.94$178.05$144.76
4 Nov 2026$178.20$177.75$144.97
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.

  • Price $178.20
  • 50-day avg $177.75
  • 200-day avg $144.97
Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$150.36$154.20$164.17
10 Nov 2023$147.56$151.95$163.17
17 Nov 2023$150.60$150.25$162.23
24 Nov 2023$161.78$150.04$161.55
1 Dec 2023$164.94$149.52$160.83
8 Dec 2023$159.27$149.40$160.20
15 Dec 2023$181.22$151.19$160.11
22 Dec 2023$182.72$153.77$160.09
29 Dec 2023$179.80$156.53$160.35
5 Jan 2024$171.63$158.90$160.36
12 Jan 2024$173.21$164.19$160.64
19 Jan 2024$178.02$166.86$160.77
26 Jan 2024$193.40$170.72$161.32
2 Feb 2024$196.17$174.65$161.75
9 Feb 2024$205.00$178.89$162.68
16 Feb 2024$208.42$183.43$164.02
23 Feb 2024$196.52$186.34$164.75
1 Mar 2024$195.52$188.21$165.75
8 Mar 2024$195.47$189.54$166.69
15 Mar 2024$189.93$190.82$167.27
22 Mar 2024$198.03$193.15$168.03
28 Mar 2024$183.92$193.99$168.40
5 Apr 2024$173.81$193.58$168.84
12 Apr 2024$171.53$192.09$169.53
19 Apr 2024$157.14$188.46$170.06
26 Apr 2024$166.58$184.65$170.58
3 May 2024$167.05$181.06$170.86
10 May 2024$166.81$178.30$170.72
17 May 2024$171.94$175.86$170.73
24 May 2024$158.16$172.89$170.54
31 May 2024$149.09$169.42$170.10
7 Jun 2024$145.78$165.26$169.76
14 Jun 2024$125.62$160.88$168.98
21 Jun 2024$125.32$156.62$167.99
28 Jun 2024$126.06$152.37$167.03
5 Jul 2024$120.08$149.19$166.18
12 Jul 2024$125.92$144.86$165.18
19 Jul 2024$123.81$141.13$164.41
26 Jul 2024$140.79$137.81$163.92
2 Aug 2024$161.67$136.52$164.03
9 Aug 2024$165.16$137.11$164.51
16 Aug 2024$147.55$138.16$165.40
23 Aug 2024$146.80$138.82$165.67
30 Aug 2024$150.93$141.24$165.68
6 Sep 2024$147.07$142.82$165.51
13 Sep 2024$139.99$144.82$165.12
20 Sep 2024$142.97$146.80$164.66
27 Sep 2024$145.93$148.25$164.28
4 Oct 2024$136.71$149.53$163.46
11 Oct 2024$138.82$147.71$162.32
18 Oct 2024$146.95$145.68$161.39
25 Oct 2024$135.45$143.38$160.55
1 Nov 2024$138.61$141.96$159.60
8 Nov 2024$140.70$141.56$158.60
15 Nov 2024$124.73$141.09$157.32
22 Nov 2024$142.58$140.26$155.71
29 Nov 2024$150.54$140.84$154.60
6 Dec 2024$149.20$141.37$153.29
13 Dec 2024$156.41$142.41$152.30
20 Dec 2024$144.46$143.97$151.21
27 Dec 2024$145.54$144.34$150.25
3 Jan 2025$149.90$144.31$149.27
10 Jan 2025$154.86$145.75$148.46
17 Jan 2025$160.51$147.98$147.87
24 Jan 2025$165.89$149.83$147.72
31 Jan 2025$166.21$152.62$147.59
7 Feb 2025$156.05$155.11$147.60
14 Feb 2025$146.92$155.08$147.13
21 Feb 2025$158.99$155.65$146.93
28 Feb 2025$159.26$156.26$146.79
7 Mar 2025$155.70$156.78$146.44
14 Mar 2025$150.62$156.68$145.95
21 Mar 2025$140.02$156.22$145.77
28 Mar 2025$133.41$154.52$145.59
4 Apr 2025$111.94$150.41$145.39
11 Apr 2025$122.86$145.25$145.25
17 Apr 2025$130.00$142.61$145.31
25 Apr 2025$144.75$141.31$145.82
2 May 2025$141.51$140.27$146.16
9 May 2025$123.24$137.16$146.18
16 May 2025$126.50$134.28$145.88
23 May 2025$118.15$131.98$144.84
30 May 2025$118.07$129.81$143.97
6 Jun 2025$128.30$128.18$143.15
13 Jun 2025$127.52$128.14$142.70
20 Jun 2025$118.85$128.64$142.15
27 Jun 2025$123.56$128.63$141.61
3 Jul 2025$127.47$128.08$141.28
11 Jul 2025$130.19$126.73$140.98
18 Jul 2025$116.25$124.96$140.40
25 Jul 2025$121.73$123.89$139.78
1 Aug 2025$118.91$123.33$139.39
8 Aug 2025$111.43$122.67$138.66
15 Aug 2025$124.34$122.70$138.21
22 Aug 2025$124.79$121.94$137.87
29 Aug 2025$122.32$121.58$137.31
5 Sep 2025$124.56$121.49$136.82
12 Sep 2025$113.54$120.83$136.50
19 Sep 2025$122.30$119.94$135.81
26 Sep 2025$125.61$120.10$135.23
3 Oct 2025$148.73$122.37$134.84
10 Oct 2025$145.24$125.06$134.76
17 Oct 2025$152.60$128.59$134.89
24 Oct 2025$166.33$132.63$135.17
31 Oct 2025$149.06$135.46$135.03
7 Nov 2025$142.82$137.92$134.56
14 Nov 2025$152.37$141.04$134.13
21 Nov 2025$162.51$144.66$133.95
28 Nov 2025$171.02$148.74$134.33
5 Dec 2025$164.98$152.95$134.72
12 Dec 2025$157.39$155.55$134.72
19 Dec 2025$162.38$156.57$134.76
26 Dec 2025$166.21$158.01$135.15
2 Jan 2026$164.35$158.85$135.50
9 Jan 2026$166.82$159.70$136.17
16 Jan 2026$162.02$161.35$136.95
23 Jan 2026$162.33$163.03$137.86
30 Jan 2026$149.37$163.62$138.83
6 Feb 2026$142.18$162.36$139.18
13 Feb 2026$136.44$159.36$139.09
20 Feb 2026$135.68$157.12$139.03
27 Feb 2026$128.73$154.33$139.14
6 Mar 2026$119.99$150.70$139.06
13 Mar 2026$114.20$146.02$139.00
20 Mar 2026$113.88$140.91$138.89
27 Mar 2026$110.12$135.72$138.52
2 Apr 2026$117.78$131.89$138.26
10 Apr 2026$120.10$127.38$138.22
17 Apr 2026$131.21$125.20$138.33
24 Apr 2026$117.60$123.45$138.24
1 May 2026$117.20$121.54$138.05
8 May 2026$123.46$120.50$138.21
15 May 2026$102.87$118.81$137.87
22 May 2026$115.06$117.81$137.73
29 May 2026$123.95$117.99$137.82
5 Jun 2026$122.31$118.72$137.76
12 Jun 2026$130.59$120.28$137.97
18 Jun 2026$132.02$121.44$138.19
26 Jun 2026$147.01$122.61$138.61
2 Jul 2026$142.40$123.24$139.05
10 Jul 2026$144.24$125.54$139.52
17 Jul 2026$147.25$128.41$140.10
24 Jul 2026$131.96$130.15$139.95
31 Jul 2026$141.01$133.68$139.76
7 Aug 2026$163.90$137.88$139.86
14 Aug 2026$166.83$142.19$139.96
21 Aug 2026$181.13$146.95$140.61
28 Aug 2026$176.27$151.78$141.49
4 Sep 2026$167.60$155.63$141.97
11 Sep 2026$165.18$157.71$142.17
18 Sep 2026$176.89$161.03$142.28
25 Sep 2026$189.68$165.02$142.83
2 Oct 2026$181.70$169.67$143.51
9 Oct 2026$173.88$173.19$143.85
16 Oct 2026$175.42$175.78$144.13
23 Oct 2026$176.93$177.10$144.39
30 Oct 2026$176.94$178.05$144.76
4 Nov 2026$178.20$177.75$144.97
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.

  • Price $178.20
  • 50-day avg $177.75
  • 200-day avg $144.97
Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$290.50$282.56$224.89
12 Nov 2021$258.50$282.91$228.33
26 Nov 2021$286.01$279.34$230.93
10 Dec 2021$247.64$271.39$233.50
23 Dec 2021$264.65$271.10$236.54
7 Jan 2022$206.79$265.84$238.80
21 Jan 2022$183.81$249.74$238.84
4 Feb 2022$200.95$234.19$237.90
18 Feb 2022$180.68$217.72$236.93
4 Mar 2022$178.80$204.88$237.56
18 Mar 2022$191.43$188.50$237.24
1 Apr 2022$188.02$185.14$237.00
14 Apr 2022$157.67$181.60$235.81
29 Apr 2022$157.24$173.44$233.31
13 May 2022$150.40$166.60$230.32
27 May 2022$170.04$163.43$225.53
10 Jun 2022$149.16$159.96$221.13
24 Jun 2022$165.88$154.83$214.96
8 Jul 2022$175.50$157.66$209.04
22 Jul 2022$201.74$161.17$202.97
5 Aug 2022$246.27$175.28$200.94
19 Aug 2022$237.75$191.90$199.26
2 Sep 2022$210.34$206.87$196.89
16 Sep 2022$221.32$217.44$194.44
30 Sep 2022$187.11$222.06$191.20
14 Oct 2022$193.54$219.91$188.32
28 Oct 2022$181.99$206.42$185.99
11 Nov 2022$199.29$197.24$185.64
25 Nov 2022$171.58$189.69$184.93
9 Dec 2022$163.32$185.06$184.43
23 Dec 2022$167.54$177.83$183.80
6 Jan 2023$154.26$174.78$183.25
20 Jan 2023$186.30$174.71$183.00
3 Feb 2023$192.91$175.19$184.17
17 Feb 2023$190.00$178.23$186.03
3 Mar 2023$188.00$179.67$187.20
17 Mar 2023$170.22$181.04$188.09
31 Mar 2023$168.36$180.06$188.48
14 Apr 2023$174.03$176.71$189.17
28 Apr 2023$151.63$170.76$188.81
12 May 2023$151.98$166.12$187.41
26 May 2023$171.02$163.18$183.70
9 Jun 2023$162.19$163.15$180.32
23 Jun 2023$149.57$161.29$177.42
7 Jul 2023$141.54$156.40$173.57
21 Jul 2023$175.34$156.20$171.69
4 Aug 2023$172.83$159.25$169.98
18 Aug 2023$157.80$159.49$169.49
1 Sep 2023$175.74$161.30$168.79
15 Sep 2023$165.50$165.19$168.11
29 Sep 2023$159.01$167.38$167.48
13 Oct 2023$152.74$163.65$166.73
27 Oct 2023$119.58$157.06$165.38
10 Nov 2023$147.56$151.95$163.17
24 Nov 2023$161.78$150.04$161.55
8 Dec 2023$159.27$149.40$160.20
22 Dec 2023$182.72$153.77$160.09
5 Jan 2024$171.63$158.90$160.36
19 Jan 2024$178.02$166.86$160.77
2 Feb 2024$196.17$174.65$161.75
16 Feb 2024$208.42$183.43$164.02
1 Mar 2024$195.52$188.21$165.75
15 Mar 2024$189.93$190.82$167.27
28 Mar 2024$183.92$193.99$168.40
12 Apr 2024$171.53$192.09$169.53
26 Apr 2024$166.58$184.65$170.58
10 May 2024$166.81$178.30$170.72
24 May 2024$158.16$172.89$170.54
7 Jun 2024$145.78$165.26$169.76
21 Jun 2024$125.32$156.62$167.99
5 Jul 2024$120.08$149.19$166.18
19 Jul 2024$123.81$141.13$164.41
2 Aug 2024$161.67$136.52$164.03
16 Aug 2024$147.55$138.16$165.40
30 Aug 2024$150.93$141.24$165.68
13 Sep 2024$139.99$144.82$165.12
27 Sep 2024$145.93$148.25$164.28
11 Oct 2024$138.82$147.71$162.32
25 Oct 2024$135.45$143.38$160.55
8 Nov 2024$140.70$141.56$158.60
22 Nov 2024$142.58$140.26$155.71
6 Dec 2024$149.20$141.37$153.29
20 Dec 2024$144.46$143.97$151.21
3 Jan 2025$149.90$144.31$149.27
17 Jan 2025$160.51$147.98$147.87
31 Jan 2025$166.21$152.62$147.59
14 Feb 2025$146.92$155.08$147.13
28 Feb 2025$159.26$156.26$146.79
14 Mar 2025$150.62$156.68$145.95
28 Mar 2025$133.41$154.52$145.59
11 Apr 2025$122.86$145.25$145.25
25 Apr 2025$144.75$141.31$145.82
9 May 2025$123.24$137.16$146.18
23 May 2025$118.15$131.98$144.84
6 Jun 2025$128.30$128.18$143.15
20 Jun 2025$118.85$128.64$142.15
3 Jul 2025$127.47$128.08$141.28
18 Jul 2025$116.25$124.96$140.40
1 Aug 2025$118.91$123.33$139.39
15 Aug 2025$124.34$122.70$138.21
29 Aug 2025$122.32$121.58$137.31
12 Sep 2025$113.54$120.83$136.50
26 Sep 2025$125.61$120.10$135.23
10 Oct 2025$145.24$125.06$134.76
24 Oct 2025$166.33$132.63$135.17
7 Nov 2025$142.82$137.92$134.56
21 Nov 2025$162.51$144.66$133.95
5 Dec 2025$164.98$152.95$134.72
19 Dec 2025$162.38$156.57$134.76
2 Jan 2026$164.35$158.85$135.50
16 Jan 2026$162.02$161.35$136.95
30 Jan 2026$149.37$163.62$138.83
13 Feb 2026$136.44$159.36$139.09
27 Feb 2026$128.73$154.33$139.14
13 Mar 2026$114.20$146.02$139.00
27 Mar 2026$110.12$135.72$138.52
10 Apr 2026$120.10$127.38$138.22
24 Apr 2026$117.60$123.45$138.24
8 May 2026$123.46$120.50$138.21
22 May 2026$115.06$117.81$137.73
5 Jun 2026$122.31$118.72$137.76
18 Jun 2026$132.02$121.44$138.19
2 Jul 2026$142.40$123.24$139.05
17 Jul 2026$147.25$128.41$140.10
31 Jul 2026$141.01$133.68$139.76
14 Aug 2026$166.83$142.19$139.96
28 Aug 2026$176.27$151.78$141.49
11 Sep 2026$165.18$157.71$142.17
25 Sep 2026$189.68$165.02$142.83
9 Oct 2026$173.88$173.19$143.85
23 Oct 2026$176.93$177.10$144.39
4 Nov 2026$178.20$177.75$144.97
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.

  • Price $178.20
  • 50-day avg $177.75
  • 200-day avg $144.97
Nov 2026: $178.20, 22.9% above its 200-day average. The price has been rising for 15 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$28.58$30.97–
18 Nov 2016$32.96$30.55–
9 Dec 2016$31.54$30.55–
30 Dec 2016$30.82$31.19–
20 Jan 2017$30.52$31.97–
10 Feb 2017$30.07$31.09–
3 Mar 2017$31.66$30.91–
24 Mar 2017$34.64$31.27–
13 Apr 2017$35.35$32.58–
5 May 2017$37.67$34.33$31.70
26 May 2017$39.26$36.29$32.44
16 Jun 2017$38.23$37.54$32.98
7 Jul 2017$41.39$39.34$33.62
28 Jul 2017$40.39$40.54$34.43
18 Aug 2017$40.21$41.20$35.35
8 Sep 2017$43.45$41.80$36.18
29 Sep 2017$38.32$41.94$36.92
20 Oct 2017$37.92$40.77$37.34
10 Nov 2017$34.73$39.57$37.86
1 Dec 2017$35.51$36.89$38.16
22 Dec 2017$35.72$35.89$38.43
12 Jan 2018$36.61$35.65$38.58
2 Feb 2018$33.82$35.72$38.66
23 Feb 2018$35.37$35.07$38.39
16 Mar 2018$36.75$35.05$38.15
6 Apr 2018$36.47$34.85$37.92
27 Apr 2018$37.30$35.99$37.59
18 May 2018$42.58$37.60$37.46
8 Jun 2018$44.24$39.72$37.60
29 Jun 2018$47.04$42.33$37.82
20 Jul 2018$48.79$45.20$38.29
10 Aug 2018$49.27$46.96$39.09
31 Aug 2018$54.88$49.04$40.19
21 Sep 2018$55.24$51.80$41.79
12 Oct 2018$54.01$53.70$43.22
2 Nov 2018$66.22$55.74$44.72
23 Nov 2018$63.94$58.43$46.85
14 Dec 2018$57.30$60.26$48.89
4 Jan 2019$50.86$59.33$49.88
25 Jan 2019$57.95$57.87$51.26
15 Feb 2019$60.19$55.92$52.76
8 Mar 2019$56.73$56.50$54.05
29 Mar 2019$59.08$58.35$55.23
18 Apr 2019$54.76$58.41$55.99
10 May 2019$69.28$60.17$57.24
31 May 2019$69.47$62.92$58.66
21 Jun 2019$83.04$68.35$60.51
12 Jul 2019$85.00$75.41$62.42
2 Aug 2019$90.61$82.09$65.11
23 Aug 2019$90.86$87.65$67.65
13 Sep 2019$79.74$89.30$69.25
4 Oct 2019$76.44$86.72$70.53
25 Oct 2019$79.16$82.60$72.48
15 Nov 2019$84.67$79.40$74.42
6 Dec 2019$90.30$81.41$76.44
27 Dec 2019$92.23$85.54$78.68
17 Jan 2020$100.71$90.14$81.27
7 Feb 2020$101.33$94.95$84.42
28 Feb 2020$85.60$97.48$86.60
20 Mar 2020$88.75$97.32$88.27
9 Apr 2020$98.95$96.02$89.47
1 May 2020$112.91$97.77$91.28
22 May 2020$139.51$109.52$94.20
12 Jun 2020$116.83$118.29$96.47
2 Jul 2020$126.65$122.83$98.69
24 Jul 2020$134.36$126.14$102.63
14 Aug 2020$143.89$130.54$107.84
4 Sep 2020$145.40$140.57$112.88
25 Sep 2020$144.30$146.22$116.88
16 Oct 2020$170.77$151.60$122.14
6 Nov 2020$201.98$160.67$128.13
27 Nov 2020$186.99$172.46$134.32
18 Dec 2020$193.90$183.14$141.20
8 Jan 2021$208.36$188.85$147.87
29 Jan 2021$200.00$194.72$155.66
19 Feb 2021$214.35$203.15$163.07
12 Mar 2021$194.70$207.01$168.20
1 Apr 2021$195.44$204.41$173.33
23 Apr 2021$218.32$203.98$180.06
14 May 2021$171.96$198.66$184.71
4 Jun 2021$177.79$193.43$186.61
25 Jun 2021$191.62$191.31$189.77
16 Jul 2021$200.14$188.38$193.70
6 Aug 2021$250.65$204.05$198.53
27 Aug 2021$275.83$226.85$204.59
17 Sep 2021$306.90$253.03$211.70
8 Oct 2021$258.78$277.81$219.60
29 Oct 2021$290.50$282.56$224.89
19 Nov 2021$284.89$280.91$229.81
10 Dec 2021$247.64$271.39$233.50
31 Dec 2021$264.84$270.61$238.10
21 Jan 2022$183.81$249.74$238.84
11 Feb 2022$188.97$225.40$237.31
4 Mar 2022$178.80$204.88$237.56
25 Mar 2022$180.55$185.56$237.18
14 Apr 2022$157.67$181.60$235.81
6 May 2022$156.97$171.34$232.27
27 May 2022$170.04$163.43$225.53
17 Jun 2022$142.75$155.83$217.72
8 Jul 2022$175.50$157.66$209.04
29 Jul 2022$213.36$166.97$201.61
19 Aug 2022$237.75$191.90$199.26
9 Sep 2022$233.57$211.54$195.78
30 Sep 2022$187.11$222.06$191.20
21 Oct 2022$167.03$213.60$186.82
11 Nov 2022$199.29$197.24$185.64
2 Dec 2022$186.05$186.38$184.70
23 Dec 2022$167.54$177.83$183.80
13 Jan 2023$178.06$173.73$183.05
3 Feb 2023$192.91$175.19$184.17
24 Feb 2023$173.44$178.84$186.41
17 Mar 2023$170.22$181.04$188.09
6 Apr 2023$162.34$178.20$188.84
28 Apr 2023$151.63$170.76$188.81
19 May 2023$159.25$163.47$185.70
9 Jun 2023$162.19$163.15$180.32
30 Jun 2023$141.46$158.14$175.28
21 Jul 2023$175.34$156.20$171.69
11 Aug 2023$172.21$159.58$169.83
1 Sep 2023$175.74$161.30$168.79
22 Sep 2023$160.55$166.93$167.71
13 Oct 2023$152.74$163.65$166.73
3 Nov 2023$150.36$154.20$164.17
24 Nov 2023$161.78$150.04$161.55
15 Dec 2023$181.22$151.19$160.11
5 Jan 2024$171.63$158.90$160.36
26 Jan 2024$193.40$170.72$161.32
16 Feb 2024$208.42$183.43$164.02
8 Mar 2024$195.47$189.54$166.69
28 Mar 2024$183.92$193.99$168.40
19 Apr 2024$157.14$188.46$170.06
10 May 2024$166.81$178.30$170.72
31 May 2024$149.09$169.42$170.10
21 Jun 2024$125.32$156.62$167.99
12 Jul 2024$125.92$144.86$165.18
2 Aug 2024$161.67$136.52$164.03
23 Aug 2024$146.80$138.82$165.67
13 Sep 2024$139.99$144.82$165.12
4 Oct 2024$136.71$149.53$163.46
25 Oct 2024$135.45$143.38$160.55
15 Nov 2024$124.73$141.09$157.32
6 Dec 2024$149.20$141.37$153.29
27 Dec 2024$145.54$144.34$150.25
17 Jan 2025$160.51$147.98$147.87
7 Feb 2025$156.05$155.11$147.60
28 Feb 2025$159.26$156.26$146.79
21 Mar 2025$140.02$156.22$145.77
11 Apr 2025$122.86$145.25$145.25
2 May 2025$141.51$140.27$146.16
23 May 2025$118.15$131.98$144.84
13 Jun 2025$127.52$128.14$142.70
3 Jul 2025$127.47$128.08$141.28
25 Jul 2025$121.73$123.89$139.78
15 Aug 2025$124.34$122.70$138.21
5 Sep 2025$124.56$121.49$136.82
26 Sep 2025$125.61$120.10$135.23
17 Oct 2025$152.60$128.59$134.89
7 Nov 2025$142.82$137.92$134.56
28 Nov 2025$171.02$148.74$134.33
19 Dec 2025$162.38$156.57$134.76
9 Jan 2026$166.82$159.70$136.17
30 Jan 2026$149.37$163.62$138.83
20 Feb 2026$135.68$157.12$139.03
13 Mar 2026$114.20$146.02$139.00
2 Apr 2026$117.78$131.89$138.26
24 Apr 2026$117.60$123.45$138.24
15 May 2026$102.87$118.81$137.87
5 Jun 2026$122.31$118.72$137.76
26 Jun 2026$147.01$122.61$138.61
17 Jul 2026$147.25$128.41$140.10
7 Aug 2026$163.90$137.88$139.86
28 Aug 2026$176.27$151.78$141.49
18 Sep 2026$176.89$161.03$142.28
9 Oct 2026$173.88$173.19$143.85
30 Oct 2026$176.94$178.05$144.76
4 Nov 2026$178.20$177.75$144.97
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Sideways from Oct 2025 to Feb 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Falling from Nov 2023 to Dec 2023; Sideways from Dec 2023 to Apr 2024; Sideways from Apr 2024 to Sep 2024; Falling from Oct 2024 to Dec 2024; Sideways from Jan 2025 to Mar 2025; Falling from Mar 2025 to Sep 2025; Sideways from Oct 2025 to Feb 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Rising from Oct 2021 to Dec 2021; Sideways from Jan 2022 to May 2022; Falling from Jun 2022 to Jul 2022; Sideways from Aug 2022 to Nov 2022; Falling from Nov 2022 to Jan 2023; Sideways from Jan 2023 to Mar 2023; Falling from Mar 2023 to Dec 2023; Sideways from Dec 2023 to Apr 2024; Sideways from Apr 2024 to Sep 2024; Falling from Oct 2024 to Dec 2024; Sideways from Jan 2025 to Mar 2025; Falling from Mar 2025 to Sep 2025; Sideways from Oct 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Sideways from Dec 2017 to Apr 2018; Sideways from May 2018 to Jul 2018; Rising from Aug 2018 to Dec 2021; Sideways from Jan 2022 to Jul 2022; Sideways from Jul 2022 to Feb 2023; Falling from Feb 2023 to Jun 2023; Sideways from Jul 2023 to Sep 2023; Falling from Sep 2023 to Nov 2023; Sideways from Nov 2023 to Mar 2024; Sideways from Apr 2024 to Sep 2024; Falling from Oct 2024 to Dec 2024; Sideways from Jan 2025 to Feb 2025; Falling from Mar 2025 to Sep 2025; Sideways from Oct 2025 to Jan 2026; Sideways from Feb 2026 to Jun 2026; Rising from Jun 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 281 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016+10.5%
14 Oct 2016+9.6%
21 Oct 2016+7.9%
28 Oct 2016+2.0%
4 Nov 2016−5.6%
11 Nov 2016+4.7%
18 Nov 2016+4.8%
25 Nov 2016+6.1%
2 Dec 2016−1.7%
9 Dec 2016−8.2%
16 Dec 2016−7.9%
23 Dec 2016−3.4%
30 Dec 2016−1.3%
6 Jan 2017+1.2%
13 Jan 2017−1.0%
20 Jan 2017−1.6%
27 Jan 2017−6.0%
3 Feb 2017−0.3%
10 Feb 2017−13.8%
17 Feb 2017−13.5%
24 Feb 2017−12.0%
3 Mar 2017−6.6%
10 Mar 2017−2.7%
17 Mar 2017+2.5%
24 Mar 2017+3.1%
31 Mar 2017+8.7%
7 Apr 2017+0.1%
13 Apr 2017+11.9%
21 Apr 2017+11.4%
28 Apr 2017+22.5%
5 May 2017+22.4%
12 May 2017+25.9%
19 May 2017+22.1%
26 May 2017+20.1%
2 Jun 2017+23.9%
9 Jun 2017+19.3%
16 Jun 2017+7.1%
23 Jun 2017+23.6%
30 Jun 2017+15.2%
7 Jul 2017+17.8%
14 Jul 2017+14.0%
21 Jul 2017+15.8%
28 Jul 2017+6.1%
4 Aug 2017+7.0%
11 Aug 2017+3.9%
18 Aug 2017+3.1%
25 Aug 2017+4.1%
1 Sep 2017+7.3%
8 Sep 2017+9.5%
15 Sep 2017+13.2%
22 Sep 2017−3.6%
29 Sep 2017−11.4%
6 Oct 2017−12.5%
13 Oct 2017−12.8%
20 Oct 2017−14.8%
27 Oct 2017−10.0%
3 Nov 2017−10.7%
10 Nov 2017−21.4%
17 Nov 2017−23.2%
24 Nov 2017−22.8%
1 Dec 2017−25.0%
8 Dec 2017−25.8%
15 Dec 2017−25.5%
22 Dec 2017−25.6%
29 Dec 2017−11.5%
5 Jan 2018−10.6%
12 Jan 2018−13.9%
19 Jan 2018−14.7%
26 Jan 2018−14.4%
2 Feb 2018−19.7%
9 Feb 2018−12.3%
16 Feb 2018−7.9%
23 Feb 2018−3.1%
2 Mar 2018−4.6%
9 Mar 2018−0.2%
16 Mar 2018−1.0%
23 Mar 2018−0.1%
29 Mar 2018+1.1%
6 Apr 2018+3.2%
13 Apr 2018+6.6%
20 Apr 2018+10.1%
27 Apr 2018+8.1%
4 May 2018+13.2%
11 May 2018+32.3%
18 May 2018+30.7%
25 May 2018+23.8%
1 Jun 2018+24.7%
8 Jun 2018+18.9%
15 Jun 2018+22.0%
22 Jun 2018+28.0%
29 Jun 2018+26.9%
6 Jul 2018+28.2%
13 Jul 2018+22.7%
20 Jul 2018+24.8%
27 Jul 2018+21.9%
3 Aug 2018+21.5%
10 Aug 2018+12.8%
17 Aug 2018+11.2%
24 Aug 2018+16.2%
31 Aug 2018+19.8%
7 Sep 2018+26.7%
14 Sep 2018+25.4%
21 Sep 2018+13.1%
28 Sep 2018+10.7%
5 Oct 2018+6.8%
12 Oct 2018+14.2%
19 Oct 2018+14.3%
26 Oct 2018+20.6%
2 Nov 2018+43.3%
9 Nov 2018+39.4%
16 Nov 2018+36.1%
23 Nov 2018+29.2%
30 Nov 2018+22.9%
7 Dec 2018+14.8%
14 Dec 2018+7.6%
21 Dec 2018+6.2%
28 Dec 2018+7.3%
4 Jan 2019+5.7%
11 Jan 2019+8.2%
18 Jan 2019+9.3%
25 Jan 2019+5.9%
1 Feb 2019−12.3%
8 Feb 2019−12.5%
15 Feb 2019−9.4%
22 Feb 2019−13.9%
1 Mar 2019−4.6%
8 Mar 2019−11.5%
15 Mar 2019−3.1%
22 Mar 2019+4.3%
29 Mar 2019+1.1%
5 Apr 2019−2.5%
12 Apr 2019−10.3%
18 Apr 2019−15.0%
26 Apr 2019+8.5%
3 May 2019+8.4%
10 May 2019+14.0%
17 May 2019+8.7%
24 May 2019+15.6%
31 May 2019+12.5%
7 Jun 2019+28.0%
14 Jun 2019+20.6%
21 Jun 2019+35.7%
28 Jun 2019+41.8%
5 Jul 2019+45.0%
12 Jul 2019+48.1%
19 Jul 2019+56.0%
26 Jul 2019+31.4%
2 Aug 2019+34.5%
9 Aug 2019+31.3%
16 Aug 2019+36.7%
23 Aug 2019+31.2%
30 Aug 2019+27.4%
6 Sep 2019+19.9%
13 Sep 2019+3.3%
20 Sep 2019−3.0%
27 Sep 2019−11.6%
4 Oct 2019−8.1%
11 Oct 2019−7.4%
18 Oct 2019−9.9%
25 Oct 2019−14.3%
1 Nov 2019−11.1%
8 Nov 2019−14.4%
15 Nov 2019−16.5%
22 Nov 2019−16.8%
29 Nov 2019−11.8%
6 Dec 2019−8.6%
13 Dec 2019+5.7%
20 Dec 2019+6.3%
27 Dec 2019+11.0%
3 Jan 2020+11.8%
10 Jan 2020+16.4%
17 Jan 2020+16.9%
24 Jan 2020+16.2%
31 Jan 2020+13.3%
7 Feb 2020+13.0%
14 Feb 2020+16.9%
21 Feb 2020+9.7%
28 Feb 2020+2.2%
6 Mar 2020+10.1%
13 Mar 2020+26.5%
20 Mar 2020+24.0%
27 Mar 2020+21.9%
3 Apr 2020+28.9%
9 Apr 2020+15.7%
17 Apr 2020+18.5%
24 Apr 2020+31.4%
1 May 2020+24.6%
8 May 2020+33.2%
15 May 2020+47.8%
22 May 2020+53.6%
29 May 2020+50.3%
5 Jun 2020+19.9%
12 Jun 2020+5.4%
19 Jun 2020−4.7%
26 Jun 2020+7.5%
2 Jul 2020+3.2%
10 Jul 2020+13.3%
17 Jul 2020+14.9%
24 Jul 2020+2.0%
31 Jul 2020+18.2%
7 Aug 2020+9.9%
14 Aug 2020−15.2%
21 Aug 2020−6.2%
28 Aug 2020−0.5%
4 Sep 2020+13.6%
11 Sep 2020+14.0%
18 Sep 2020+19.2%
25 Sep 2020+14.3%
2 Oct 2020+10.0%
9 Oct 2020+26.0%
16 Oct 2020+19.2%
23 Oct 2020+23.4%
30 Oct 2020+10.4%
6 Nov 2020+27.6%
13 Nov 2020+36.6%
20 Nov 2020+22.9%
27 Nov 2020+20.8%
4 Dec 2020+21.6%
11 Dec 2020+15.4%
18 Dec 2020+21.2%
24 Dec 2020+23.4%
31 Dec 2020+17.4%
8 Jan 2021+12.3%
15 Jan 2021+18.0%
22 Jan 2021+13.7%
29 Jan 2021+6.7%
5 Feb 2021−0.8%
12 Feb 2021+0.4%
19 Feb 2021+1.0%
26 Feb 2021+9.0%
5 Mar 2021−4.9%
12 Mar 2021+0.1%
19 Mar 2021−0.3%
26 Mar 2021−13.5%
1 Apr 2021−5.2%
9 Apr 2021−9.0%
16 Apr 2021−12.1%
23 Apr 2021−9.3%
30 Apr 2021−6.9%
7 May 2021−24.3%
14 May 2021−30.1%
21 May 2021−22.4%
28 May 2021−24.5%
4 Jun 2021−14.7%
11 Jun 2021−9.3%
18 Jun 2021−9.8%
25 Jun 2021−3.3%
2 Jul 2021−5.0%
9 Jul 2021−6.0%
16 Jul 2021−9.5%
23 Jul 2021−9.4%
30 Jul 2021+11.0%
6 Aug 2021+28.6%
13 Aug 2021+43.0%
20 Aug 2021+39.1%
27 Aug 2021+43.9%
3 Sep 2021+57.3%
10 Sep 2021+49.1%
17 Sep 2021+49.1%
24 Sep 2021+64.6%
1 Oct 2021+39.4%
8 Oct 2021+25.2%
15 Oct 2021+30.0%
22 Oct 2021+28.0%
29 Oct 2021+13.5%
5 Nov 2021+0.6%
12 Nov 2021−4.6%
19 Nov 2021+2.7%
26 Nov 2021+1.8%
3 Dec 2021−10.2%
10 Dec 2021−21.7%
17 Dec 2021−17.7%
23 Dec 2021−24.1%
31 Dec 2021−15.3%
7 Jan 2022−26.5%
14 Jan 2022−31.8%
21 Jan 2022−29.8%
28 Jan 2022−30.8%
4 Feb 2022−20.5%
11 Feb 2022−21.2%
18 Feb 2022−29.2%
25 Feb 2022−28.2%
4 Mar 2022−27.3%
11 Mar 2022−21.8%
18 Mar 2022−24.5%
25 Mar 2022−28.0%
1 Apr 2022−24.4%
8 Apr 2022−13.8%
14 Apr 2022−12.6%
22 Apr 2022−18.1%
29 Apr 2022−10.5%
6 May 2022−13.6%
13 May 2022−11.6%
20 May 2022−4.2%
27 May 2022−6.3%
3 Jun 2022−2.6%
10 Jun 2022−3.5%
17 Jun 2022−7.7%
24 Jun 2022+5.7%
1 Jul 2022+4.4%
8 Jul 2022+16.4%
15 Jul 2022+17.8%
22 Jul 2022+45.8%
29 Jul 2022+35.7%
5 Aug 2022+56.4%
12 Aug 2022+60.8%
19 Aug 2022+45.5%
26 Aug 2022+36.0%
2 Sep 2022+31.8%
9 Sep 2022+52.3%
16 Sep 2022+49.7%
23 Sep 2022+14.9%
30 Sep 2022+18.7%
7 Oct 2022+26.3%
14 Oct 2022+23.2%
21 Oct 2022−11.9%
28 Oct 2022−9.1%
4 Nov 2022−20.2%
11 Nov 2022−14.0%
18 Nov 2022−19.8%
25 Nov 2022−23.7%
2 Dec 2022−15.3%
9 Dec 2022−26.8%
16 Dec 2022−24.9%
23 Dec 2022−11.6%
30 Dec 2022−16.6%
6 Jan 2023−33.5%
13 Jan 2023−19.4%
20 Jan 2023+5.8%
27 Jan 2023+2.9%
3 Feb 2023+1.1%
10 Feb 2023−10.1%
17 Feb 2023+5.2%
24 Feb 2023+2.6%
3 Mar 2023+1.7%
10 Mar 2023+3.7%
17 Mar 2023+1.5%
24 Mar 2023−7.7%
31 Mar 2023−7.6%
6 Apr 2023−0.2%
14 Apr 2023−5.8%
21 Apr 2023−15.0%
28 Apr 2023−24.8%
5 May 2023−17.0%
12 May 2023−18.2%
19 May 2023−19.0%
26 May 2023−7.4%
2 Jun 2023−16.9%
9 Jun 2023−13.9%
16 Jun 2023−20.2%
23 Jun 2023−16.1%
30 Jun 2023−24.3%
7 Jul 2023−20.0%
14 Jul 2023−22.5%
21 Jul 2023−4.1%
28 Jul 2023+5.0%
4 Aug 2023−0.4%
11 Aug 2023+5.0%
18 Aug 2023−5.2%
25 Aug 2023−8.4%
1 Sep 2023−0.4%
8 Sep 2023−4.1%
15 Sep 2023+4.2%
22 Sep 2023+8.0%
29 Sep 2023+16.0%
6 Oct 2023+10.6%
13 Oct 2023+5.5%
20 Oct 2023−9.9%
27 Oct 2023−21.2%
3 Nov 2023−10.3%
10 Nov 2023−13.2%
17 Nov 2023−7.8%
24 Nov 2023−5.3%
1 Dec 2023−7.9%
8 Dec 2023−4.6%
15 Dec 2023+3.6%
22 Dec 2023+3.8%
29 Dec 2023+1.9%
5 Jan 2024+2.8%
12 Jan 2024+2.9%
19 Jan 2024+7.4%
26 Jan 2024+43.0%
2 Feb 2024+16.7%
9 Feb 2024+25.2%
16 Feb 2024+27.6%
23 Feb 2024+9.9%
1 Mar 2024+6.8%
8 Mar 2024+11.5%
15 Mar 2024−3.8%
22 Mar 2024−1.7%
28 Mar 2024−7.8%
5 Apr 2024−9.5%
12 Apr 2024−8.1%
19 Apr 2024−14.4%
26 Apr 2024−18.1%
3 May 2024−18.3%
10 May 2024−22.5%
17 May 2024−23.5%
24 May 2024−23.8%
31 May 2024−26.6%
7 Jun 2024−29.8%
14 Jun 2024−40.3%
21 Jun 2024−41.2%
28 Jun 2024−35.5%
5 Jul 2024−37.9%
12 Jul 2024−36.2%
19 Jul 2024−32.1%
26 Jul 2024−22.6%
2 Aug 2024−7.4%
9 Aug 2024−3.3%
16 Aug 2024−18.9%
23 Aug 2024−13.4%
30 Aug 2024−5.7%
6 Sep 2024−0.3%
13 Sep 2024+7.9%
20 Sep 2024+9.7%
27 Sep 2024+10.8%
4 Oct 2024+10.5%
11 Oct 2024+6.7%
18 Oct 2024+12.2%
25 Oct 2024−10.1%
1 Nov 2024−21.4%
8 Nov 2024−27.0%
15 Nov 2024−21.1%
22 Nov 2024−8.8%
29 Nov 2024−7.2%
6 Dec 2024−11.0%
13 Dec 2024+4.2%
20 Dec 2024−3.0%
27 Dec 2024−4.4%
3 Jan 2025+6.3%
10 Jan 2025+11.4%
17 Jan 2025+7.0%
24 Jan 2025+17.5%
31 Jan 2025+14.5%
7 Feb 2025+10.5%
14 Feb 2025+13.7%
21 Feb 2025+10.8%
28 Feb 2025+7.2%
7 Mar 2025+9.6%
14 Mar 2025+3.2%
21 Mar 2025+1.5%
28 Mar 2025−1.7%
4 Apr 2025−10.7%
11 Apr 2025−12.6%
17 Apr 2025−7.1%
25 Apr 2025−3.3%
2 May 2025−9.0%
9 May 2025−15.0%
16 May 2025−11.4%
23 May 2025−22.2%
30 May 2025−25.1%
6 Jun 2025−21.6%
13 Jun 2025−21.4%
20 Jun 2025−20.5%
27 Jun 2025−18.0%
3 Jul 2025−9.9%
11 Jul 2025−10.8%
18 Jul 2025−29.8%
25 Jul 2025−31.6%
1 Aug 2025−25.7%
8 Aug 2025−22.5%
15 Aug 2025−10.0%
22 Aug 2025−5.8%
29 Aug 2025−5.8%
5 Sep 2025−10.9%
12 Sep 2025−21.1%
19 Sep 2025−8.8%
26 Sep 2025−6.0%
3 Oct 2025+9.7%
10 Oct 2025+6.8%
17 Oct 2025+25.4%
24 Oct 2025+30.3%
31 Oct 2025+15.6%
7 Nov 2025+22.9%
14 Nov 2025+18.1%
21 Nov 2025+28.1%
28 Nov 2025+33.9%
5 Dec 2025+26.5%
12 Dec 2025+34.9%
19 Dec 2025+30.2%
26 Dec 2025+28.0%
2 Jan 2026+8.4%
9 Jan 2026+8.6%
16 Jan 2026+2.1%
23 Jan 2026−4.2%
30 Jan 2026−1.2%
6 Feb 2026−3.4%
13 Feb 2026−11.9%
20 Feb 2026−21.1%
27 Feb 2026−25.1%
6 Mar 2026−25.3%
13 Mar 2026−24.6%
20 Mar 2026−25.2%
27 Mar 2026−25.6%
2 Apr 2026−24.3%
10 Apr 2026−25.9%
17 Apr 2026−21.7%
24 Apr 2026−31.1%
1 May 2026−25.7%
8 May 2026−20.0%
15 May 2026−33.0%
22 May 2026−23.4%
29 May 2026−14.0%
5 Jun 2026−7.8%
12 Jun 2026+2.4%
18 Jun 2026+0.8%
26 Jun 2026+18.5%
2 Jul 2026+7.3%
10 Jul 2026+9.0%
17 Jul 2026+7.6%
24 Jul 2026+8.7%
31 Jul 2026+16.7%
7 Aug 2026+27.9%
14 Aug 2026+57.1%
21 Aug 2026+54.7%
28 Aug 2026+40.5%
4 Sep 2026+32.6%
11 Sep 2026+23.4%
18 Sep 2026+32.0%
25 Sep 2026+23.2%
2 Oct 2026+24.3%
9 Oct 2026+17.4%
16 Oct 2026+16.4%
23 Oct 2026+31.2%
30 Oct 2026+24.3%
4 Nov 2026+9.6%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved +542% while the S&P 500 moved +261%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Repligen pay?

Repligen Corporation pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is Repligen on?

Repligen is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Repligen profitable?

Repligen Corporation earned $5.0 M of net profit in the Jun 2026 quarter, −66.3% on the same quarter a year earlier. Full-year FY25 profit was $48.9 M. Over 4 years profit has grown −21.4% a year on average. That is 2.5% of the quarter's revenue. The same quarter a year earlier earned $14.9 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

3 of the last 12 reported quarters were loss-making.

FY25 profit $48.9 M, −21.4% a year over 4 years

  • Net profit $48.9 M
FY25 profit $48.9 M, −21.4% a year over 4 years
QuarterNet profit
FY21$128 M
FY22$186 M
FY23$35.6 M
FY24−$25.5 M
FY25$48.9 M

Growth on a year earlier

  • Growth on a year earlier −171.7%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2245%
FY23−80.9%
FY24−171.7%
FY25–
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $5.0 M (−66.3% on a year earlier)

  • Net profit (quarterly) $5.0 M
Jun 2026: $5.0 M (−66.3% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023$16.9 M
Dec 2023−$16.4 M
Mar 2024$3.3 M
Jun 2024$5.7 M
Sep 2024−$0.7 M
Dec 2024−$33.9 M
Mar 2025$5.8 M
Jun 2025$14.9 M
Sep 2025$14.9 M
Dec 2025$13.3 M
Mar 2026$8.3 M
Jun 2026$5.0 M

Growth on a year earlier

  • Growth on a year earlier −66.3%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−58.1%
Dec 2023−133.8%
Mar 2024−78.5%
Jun 2024−71.1%
Sep 2024−103.9%
Dec 2024–
Mar 202576.9%
Jun 2025160.2%
Sep 2025–
Dec 2025–
Mar 202642.9%
Jun 2026−66.3%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does Repligen make, and is it growing?

Repligen Corporation reported $204 M of revenue in the Jun 2026 quarter, +11.9% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 4 years it has grown 2.4% a year on average. The last full year, FY25, came in at $738 M.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $785 M.

FY25 revenue was $738 M, +16.4% on the year before.

FY25 revenue $738 M (+16.4% on the year before), 2.4% a year over 4 years

  • Revenue $738 M
FY25 revenue $738 M (+16.4% on the year before), 2.4% a year over 4 years
QuarterRevenue
FY21$671 M
FY22$802 M
FY23$632 M
FY24$634 M
FY25$738 M

Growth on a year earlier

  • Growth on a year earlier 16.4%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2219.5%
FY23−21.1%
FY240.3%
FY2516.4%
Top: revenue each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $204 M (+11.9% on a year earlier), the 8th quarter in a row of growth

  • Revenue (quarterly) $204 M
Jun 2026: $204 M (+11.9% on a year earlier), the 8th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$141 M
Dec 2023$167 M
Mar 2024$153 M
Jun 2024$159 M
Sep 2024$155 M
Dec 2024$168 M
Mar 2025$169 M
Jun 2025$182 M
Sep 2025$189 M
Dec 2025$198 M
Mar 2026$194 M
Jun 2026$204 M

Growth on a year earlier

  • Growth on a year earlier 11.9%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−29.7%
Dec 2023−10.8%
Mar 2024−7.4%
Jun 2024−0.2%
Sep 20249.7%
Dec 20240.6%
Mar 202510.4%
Jun 202514.8%
Sep 202521.9%
Dec 202518.1%
Mar 202614.8%
Jun 202611.9%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +16.7% on average, against 2.4% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +16.5%, against +12.5% a year over the last 8 quarters (accelerating).

How much of every $100 of sales does Repligen keep?

Repligen Corporation's operating margin was 9.3% in the Jun 2026 quarter, 4.8 percentage points higher than the same quarter a year ago. Across 5 years it has been between 5.9% and 25.8%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +4.8 percentage points on the year while gross margin changed +2.9 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY25: 6.2%, within a range of 5.9% to 25.8% over 5 years

  • Operating margin 6.2%
FY25: 6.2%, within a range of 5.9% to 25.8% over 5 years
QuarterOperating margin
FY2125.8%
FY2224.4%
FY237.8%
FY245.9%
FY256.2%

Change on the year before (points)

  • Change on the year before (points) +0.3 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−1.4 pts
FY23−16.6 pts
FY24−1.9 pts
FY25+0.3 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 9.3% (+4.8 points on a year earlier)

  • Operating margin 9.3%
Jun 2026: operating margin 9.3% (+4.8 points on a year earlier)
QuarterOperating margin
Sep 2023−4%
Dec 202311.3%
Mar 20243.4%
Jun 20247.2%
Sep 20248.2%
Dec 20245%
Mar 20255.1%
Jun 20254.5%
Sep 20256.7%
Dec 20258.3%
Mar 20268.9%
Jun 20269.3%

Change on a year earlier (points)

  • Change on a year earlier (points) +4.8 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023−29.1 pts
Dec 2023−5.7 pts
Mar 2024−5.7 pts
Jun 2024−6.0 pts
Sep 2024+12.2 pts
Dec 2024−6.3 pts
Mar 2025+1.7 pts
Jun 2025−2.7 pts
Sep 2025−1.5 pts
Dec 2025+3.3 pts
Mar 2026+3.8 pts
Jun 2026+4.8 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Repligen's profit turning into cash?

Over the last 3 years, 149% of Repligen Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $117 M of operating cash against $48.9 M of profit. After $23.5 M of spending on assets, $93.9 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $117 M against profit $48.9 M; 149% of 3 years' profit came in as cash

  • Operating cash $117 M
  • Net profit $48.9 M
  • Free cash $93.9 M
FY25: operating cash $117 M against profit $48.9 M; 149% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$119 M$128 M$51.9 M
FY22$172 M$186 M$87.2 M
FY23$114 M$35.6 M$77.7 M
FY24$175 M−$25.5 M$150 M
FY25$117 M$48.9 M$93.9 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $32.8 M = 654% of the quarter's profit

  • Operating cash (quarterly) $32.8 M
Jun 2026: operating cash $32.8 M = 654% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$39.2 M
Dec 2023$29.1 M
Mar 2024$44.7 M
Jun 2024$42.2 M
Sep 2024$49.3 M
Dec 2024$39.2 M
Mar 2025$15.0 M
Jun 2025$28.6 M
Sep 2025$48.1 M
Dec 2025$25.7 M
Mar 2026$28.3 M
Jun 2026$32.8 M

Operating cash as % of profit

  • Operating cash as % of profit 654%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023232%
Dec 2023–
Mar 20241,356%
Jun 2024738%
Sep 2024–
Dec 2024–
Mar 2025257%
Jun 2025192%
Sep 2025323%
Dec 2025193%
Mar 2026340%
Jun 2026654%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Repligen's cash go?

Repligen Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $85.4 M on assets over the last 3 years. Averaged over those years that is 3.9% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $85.4 M over the last 3 years.

FY25: capex $23.5 M, steady spending

  • Capex $23.5 M
FY25: capex $23.5 M, steady spending
QuarterCapex
FY21$67.1 M
FY22$84.8 M
FY23$36.2 M
FY24$25.7 M
FY25$23.5 M
Capital spending each year, $ M.

Jun 2026: capex $5.3 M in the quarter

  • Capex (quarterly) $5.3 M
Jun 2026: capex $5.3 M in the quarter
QuarterCapex (quarterly)
Sep 2023$8.4 M
Dec 2023$11.1 M
Mar 2024$8.3 M
Jun 2024$4.8 M
Sep 2024$7.0 M
Dec 2024$5.5 M
Mar 2025$3.6 M
Jun 2025$7.1 M
Sep 2025$4.7 M
Dec 2025$8.2 M
Mar 2026$4.7 M
Jun 2026$5.3 M

Free cash

  • Free cash $27.4 M
Free cash
QuarterFree cash
Sep 2023$30.8 M
Dec 2023$18.0 M
Mar 2024$36.4 M
Jun 2024$37.4 M
Sep 2024$42.3 M
Dec 2024$33.6 M
Mar 2025$11.4 M
Jun 2025$21.5 M
Sep 2025$43.4 M
Dec 2025$17.6 M
Mar 2026$23.6 M
Jun 2026$27.4 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Repligen's P/E ratio, and how does it compare with its own history?

Repligen Corporation's P/E is 246.9×, in the middle of its own history: higher than 65% of past readings. Its usual P/E (the middle reading) is 138.0×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 246.9× against a usual 138.0×: in the middle of its own history: higher than 65% of past readings

  • P/E 245.1×
  • Median 138.0×
P/E 246.9× against a usual 138.0×: in the middle of its own history: higher than 65% of past readings
WeekP/EMedian
1 Apr 202274.4×138.0×
8 Apr 202267.3×138.0×
14 Apr 202262.4×138.0×
22 Apr 202257.6×138.0×
29 Apr 202262.2×138.0×
6 May 202262.1×138.0×
13 May 202259.5×138.0×
20 May 202261.1×138.0×
27 May 202267.3×138.0×
3 Jun 202265.4×138.0×
10 Jun 202259.0×138.0×
17 Jun 202256.5×138.0×
24 Jun 202265.6×138.0×
1 Jul 202260.2×138.0×
8 Jul 202263.4×138.0×
15 Jul 202260.3×138.0×
22 Jul 202272.9×138.0×
29 Jul 202277.1×138.0×
5 Aug 202289.0×138.0×
12 Aug 202290.8×138.0×
19 Aug 202285.9×138.0×
26 Aug 202282.1×138.0×
2 Sep 202276.0×138.0×
9 Sep 202284.4×138.0×
16 Sep 202280.0×138.0×
23 Sep 202265.5×138.0×
30 Sep 202264.6×138.0×
7 Oct 202272.5×138.0×
14 Oct 202266.8×138.0×
21 Oct 202257.7×138.0×
28 Oct 202262.8×138.0×
4 Nov 202260.2×138.0×
11 Nov 202268.8×138.0×
18 Nov 202260.7×138.0×
25 Nov 202259.2×138.0×
2 Dec 202264.2×138.0×
9 Dec 202256.4×138.0×
16 Dec 202256.9×138.0×
23 Dec 202257.8×138.0×
30 Dec 202258.4×138.0×
6 Jan 202347.5×138.0×
13 Jan 202354.8×138.0×
20 Jan 202357.4×138.0×
27 Jan 202360.1×138.0×
3 Feb 202359.4×138.0×
10 Feb 202356.6×138.0×
17 Feb 202358.5×138.0×
24 Feb 202353.4×138.0×
3 Mar 202357.9×138.0×
10 Mar 202351.2×138.0×
17 Mar 202352.4×138.0×
24 Mar 202349.3×138.0×
31 Mar 202362.1×138.0×
6 Apr 202359.8×138.0×
14 Apr 202364.2×138.0×
21 Apr 202361.2×138.0×
28 Apr 202355.9×138.0×
5 May 202359.0×138.0×
12 May 202356.0×138.0×
19 May 202358.7×138.0×
26 May 202363.0×138.0×
2 Jun 202361.6×138.0×
9 Jun 202359.8×138.0×
16 Jun 202358.0×138.0×
23 Jun 202355.1×138.0×
30 Jun 202364.8×138.0×
7 Jul 202364.8×138.0×
14 Jul 202368.9×138.0×
21 Jul 202380.3×138.0×
28 Jul 202379.8×138.0×
4 Aug 202379.2×138.0×
11 Aug 202378.9×138.0×
18 Aug 202372.3×138.0×
25 Aug 202375.5×138.0×
1 Sep 202380.5×138.0×
8 Sep 202373.9×138.0×
15 Sep 202375.8×138.0×
22 Sep 202373.5×138.0×
29 Sep 202372.8×138.0×
6 Oct 202386.6×138.0×
13 Oct 202386.2×138.0×
20 Oct 202382.3×138.0×
27 Oct 202367.5×138.0×
3 Nov 202384.8×138.0×
10 Nov 202383.2×138.0×
17 Nov 202384.9×138.0×
24 Nov 202391.3×138.0×
1 Dec 202393.0×138.0×
8 Dec 202389.8×138.0×
15 Dec 2023102.2×138.0×
22 Dec 2023103.1×138.0×
29 Dec 2023101.4×138.0×
5 Jan 2024274.6×138.0×
12 Jan 2024277.1×138.0×
19 Jan 2024284.8×138.0×
26 Jan 2024309.4×138.0×
2 Feb 2024313.9×138.0×
9 Feb 2024328.0×138.0×
16 Feb 2024333.5×138.0×
23 Feb 2024314.4×138.0×
1 Mar 2024312.8×138.0×
8 Mar 2024312.8×138.0×
15 Mar 2024303.9×138.0×
22 Mar 2024316.9×138.0×
28 Mar 2024294.3×138.0×
5 Apr 2024414.1×138.0×
12 Apr 2024414.1×138.0×
19 Apr 2024379.6×138.0×
26 Apr 2024402.4×138.0×
3 May 2024403.5×138.0×
10 May 2024402.9×138.0×
17 May 2024414.1×138.0×
24 May 2024382.0×138.0×
31 May 2024360.1×138.0×
7 Jun 2024352.1×138.0×
14 Jun 2024303.4×138.0×
21 Jun 2024302.7×138.0×
28 Jun 2024304.5×138.0×
5 Jul 2024414.1×138.0×
12 Jul 2024414.1×138.0×
19 Jul 2024414.1×138.0×
26 Jul 2024414.1×138.0×
2 Aug 2024414.1×138.0×
9 Aug 2024414.1×138.0×
16 Aug 2024414.1×138.0×
23 Aug 2024414.1×138.0×
30 Aug 2024414.1×138.0×
6 Sep 2024414.1×138.0×
13 Sep 2024414.1×138.0×
20 Sep 2024414.1×138.0×
27 Sep 2024414.1×138.0×
4 Oct 2024414.1×138.0×
11 Oct 2024414.1×138.0×
18 Oct 2024414.1×138.0×
25 Oct 2024414.1×138.0×
1 Nov 2024414.1×138.0×
8 Nov 2024414.1×138.0×
15 Nov 2024414.1×138.0×
22 Nov 2024414.1×138.0×
29 Nov 2024414.1×138.0×
6 Dec 2024414.1×138.0×
13 Dec 2024414.1×138.0×
20 Dec 2024414.1×138.0×
27 Dec 2024414.1×138.0×
3 Jan 2025414.1×138.0×
10 Jan 2025414.1×138.0×
17 Jan 2025414.1×138.0×
24 Jan 2025414.1×138.0×
31 Jan 2025414.1×138.0×
3 Oct 2025414.1×138.0×
10 Oct 2025414.1×138.0×
17 Oct 2025414.1×138.0×
24 Oct 2025414.1×138.0×
31 Oct 2025414.1×138.0×
7 Nov 2025414.1×138.0×
14 Nov 2025414.1×138.0×
21 Nov 2025414.1×138.0×
28 Nov 2025414.1×138.0×
5 Dec 2025414.1×138.0×
12 Dec 2025414.1×138.0×
19 Dec 2025414.1×138.0×
26 Dec 2025414.1×138.0×
2 Jan 2026193.3×138.0×
9 Jan 2026196.3×138.0×
16 Jan 2026190.6×138.0×
23 Jan 2026191.0×138.0×
30 Jan 2026175.7×138.0×
6 Feb 2026167.3×138.0×
13 Feb 2026160.5×138.0×
20 Feb 2026159.6×138.0×
27 Feb 2026151.4×138.0×
6 Mar 2026141.2×138.0×
13 Mar 2026134.3×138.0×
20 Mar 2026134.0×138.0×
27 Mar 2026129.6×138.0×
2 Apr 2026131.2×138.0×
10 Apr 2026133.7×138.0×
17 Apr 2026146.1×138.0×
24 Apr 2026131.0×138.0×
1 May 2026130.5×138.0×
8 May 2026137.5×138.0×
15 May 2026114.5×138.0×
22 May 2026128.1×138.0×
29 May 2026138.0×138.0×
5 Jun 2026136.2×138.0×
12 Jun 2026145.4×138.0×
18 Jun 2026147.0×138.0×
26 Jun 2026163.7×138.0×
2 Jul 2026195.9×138.0×
10 Jul 2026198.4×138.0×
17 Jul 2026202.5×138.0×
24 Jul 2026181.5×138.0×
31 Jul 2026194.0×138.0×
7 Aug 2026225.4×138.0×
14 Aug 2026229.5×138.0×
21 Aug 2026249.2×138.0×
28 Aug 2026242.5×138.0×
4 Sep 2026230.5×138.0×
11 Sep 2026227.2×138.0×
18 Sep 2026243.3×138.0×
25 Sep 2026260.9×138.0×
2 Oct 2026249.9×138.0×
9 Oct 2026239.2×138.0×
16 Oct 2026241.3×138.0×
23 Oct 2026243.4×138.0×
30 Oct 2026243.4×138.0×
4 Nov 2026245.1×138.0×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.73
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Apr 2022–
8 Apr 2022–
14 Apr 2022–
22 Apr 2022–
29 Apr 2022–
6 May 2022–
13 May 2022–
20 May 2022–
27 May 2022–
3 Jun 2022–
10 Jun 2022–
17 Jun 2022–
24 Jun 2022$2.53
1 Jul 2022$2.53
8 Jul 2022$2.53
15 Jul 2022$2.53
22 Jul 2022$2.53
29 Jul 2022$2.53
5 Aug 2022$2.53
12 Aug 2022$2.53
19 Aug 2022$2.53
26 Aug 2022$2.53
2 Sep 2022$2.53
9 Sep 2022$2.53
16 Sep 2022$2.53
23 Sep 2022$2.53
30 Sep 2022$2.90
7 Oct 2022$2.90
14 Oct 2022$2.90
21 Oct 2022$2.90
28 Oct 2022$2.90
4 Nov 2022$2.90
11 Nov 2022$2.90
18 Nov 2022$2.90
25 Nov 2022$2.90
2 Dec 2022$2.90
9 Dec 2022$2.90
16 Dec 2022$2.90
23 Dec 2022$2.90
30 Dec 2022$2.90
6 Jan 2023$2.90
13 Jan 2023$2.90
20 Jan 2023$2.90
27 Jan 2023$2.90
3 Feb 2023$2.90
10 Feb 2023$2.90
17 Feb 2023$2.90
24 Feb 2023$2.90
3 Mar 2023$2.90
10 Mar 2023$2.90
17 Mar 2023$2.90
24 Mar 2023$2.90
31 Mar 2023$2.71
6 Apr 2023$2.71
14 Apr 2023$2.71
21 Apr 2023$2.71
28 Apr 2023$2.71
5 May 2023$2.71
12 May 2023$2.71
19 May 2023$2.71
26 May 2023$2.71
2 Jun 2023$2.71
9 Jun 2023$2.71
16 Jun 2023$2.71
23 Jun 2023$2.71
30 Jun 2023$2.18
7 Jul 2023$2.18
14 Jul 2023$2.18
21 Jul 2023$2.18
28 Jul 2023$2.18
4 Aug 2023$2.18
11 Aug 2023$2.18
18 Aug 2023$2.18
25 Aug 2023$2.18
1 Sep 2023$2.18
8 Sep 2023$2.18
15 Sep 2023$2.18
22 Sep 2023$2.18
29 Sep 2023$2.18
6 Oct 2023$2.18
13 Oct 2023$2.18
20 Oct 2023$2.18
27 Oct 2023$2.18
3 Nov 2023$2.18
10 Nov 2023$2.18
17 Nov 2023$2.18
24 Nov 2023$2.18
1 Dec 2023$2.18
8 Dec 2023$2.18
15 Dec 2023$2.18
22 Dec 2023$2.18
29 Dec 2023$1.77
5 Jan 2024$1.77
12 Jan 2024$1.77
19 Jan 2024$1.77
26 Jan 2024$1.77
2 Feb 2024$1.77
9 Feb 2024$1.77
16 Feb 2024$1.77
23 Feb 2024$1.77
1 Mar 2024$1.77
8 Mar 2024$1.77
15 Mar 2024$1.77
22 Mar 2024$1.77
28 Mar 2024$0.63
5 Apr 2024$0.63
12 Apr 2024$0.63
19 Apr 2024$0.63
26 Apr 2024$0.63
3 May 2024$0.63
10 May 2024$0.63
17 May 2024$0.63
24 May 2024$0.63
31 May 2024$0.63
7 Jun 2024$0.63
14 Jun 2024$0.63
21 Jun 2024$0.63
28 Jun 2024$0.41
5 Jul 2024$0.41
12 Jul 2024$0.41
19 Jul 2024$0.41
26 Jul 2024$0.41
2 Aug 2024$0.41
9 Aug 2024$0.41
16 Aug 2024$0.41
23 Aug 2024$0.41
30 Aug 2024$0.41
6 Sep 2024$0.41
13 Sep 2024$0.41
20 Sep 2024$0.41
27 Sep 2024$0.16
4 Oct 2024$0.16
11 Oct 2024$0.16
18 Oct 2024$0.16
25 Oct 2024$0.16
1 Nov 2024$0.16
8 Nov 2024$0.16
15 Nov 2024$0.16
22 Nov 2024$0.16
29 Nov 2024$0.16
6 Dec 2024$0.16
13 Dec 2024$0.16
20 Dec 2024$0.16
27 Dec 2024$0.16
3 Jan 2025$0.16
10 Jan 2025$0.16
17 Jan 2025$0.16
24 Jan 2025$0.16
31 Jan 2025$0.16
3 Oct 2025$0.16
10 Oct 2025$0.16
17 Oct 2025$0.16
24 Oct 2025$0.16
31 Oct 2025$0.16
7 Nov 2025$0.16
14 Nov 2025$0.16
21 Nov 2025$0.16
28 Nov 2025$0.16
5 Dec 2025$0.16
12 Dec 2025$0.16
19 Dec 2025$0.16
26 Dec 2025$0.01
2 Jan 2026$0.01
9 Jan 2026$0.01
16 Jan 2026$0.01
23 Jan 2026$0.01
30 Jan 2026$0.01
6 Feb 2026$0.01
13 Feb 2026$0.01
20 Feb 2026$0.01
27 Feb 2026$0.01
6 Mar 2026$0.01
13 Mar 2026$0.01
20 Mar 2026$0.01
27 Mar 2026$0.85
2 Apr 2026$0.85
10 Apr 2026$0.85
17 Apr 2026$0.85
24 Apr 2026$0.85
1 May 2026$0.85
8 May 2026$0.85
15 May 2026$0.85
22 May 2026$0.85
29 May 2026$0.85
5 Jun 2026$0.85
12 Jun 2026$0.85
18 Jun 2026$0.85
26 Jun 2026$0.90
2 Jul 2026$0.90
10 Jul 2026$0.90
17 Jul 2026$0.90
24 Jul 2026$0.90
31 Jul 2026$0.90
7 Aug 2026$0.90
14 Aug 2026$0.90
21 Aug 2026$0.90
28 Aug 2026$0.90
4 Sep 2026$0.90
11 Sep 2026$0.90
18 Sep 2026$0.90
25 Sep 2026$0.73
2 Oct 2026$0.73
9 Oct 2026$0.73
16 Oct 2026$0.73
23 Oct 2026$0.73
30 Oct 2026$0.73
4 Nov 2026$0.73
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.6 years of history; short peaks above 414× are drawn at the top edge.

PEG 3.22 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 3.22×
  • PEG = 1.0 1.00×
PEG 3.22 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Sep 20212.90×1.00×
Dec 20213.30×1.00×
Mar 20222.46×1.00×
Jun 20222.40×1.00×
Sep 20222.76×1.00×
Dec 20224.56×1.00×
Mar 20236.00×1.00×
Jun 20236.00×1.00×
Sep 20235.54×1.00×
Dec 20235.72×1.00×
Mar 20246.00×1.00×
Jun 20242.43×1.00×
Sep 20242.47×1.00×
Dec 20242.81×1.00×
Mar 20251.90×1.00×
Jun 20251.36×1.00×
Sep 20251.44×1.00×
Dec 20252.52×1.00×
Mar 20262.50×1.00×
Jun 20263.22×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters; values above 6 are drawn at the top edge.
246.9×P/E · higher than 65% of its last 4.6 years
3.00PEG · today, as reported

Where the price move came from: over 3 years the price moved +5.8% a year; about −25.7% a year came from earnings growth and about +31.5 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Is the Repligen business getting better or worse?

Repligen Corporation's business is getting worse. Profit and EPS growth are shrinking: profit growth is −245.8% in the latest quarter, against −39.4% at its best in 12 quarters, with ROCE steady at 2.3%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +16.4% in FY25

  • Revenue growth 16.4%
Growth year by year: revenue +16.4% in FY25
QuarterRevenue growth
FY21–
FY2219.5%
FY23−21.1%
FY240.3%
FY2516.4%

Profit growth, EPS growth

  • Profit growth −171.7%
  • EPS growth −173%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY2245%44.8%
FY23−80.9%−80.6%
FY24−171.7%−173%
FY25––
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating

  • Revenue 16.5%
Three growth lines over twelve quarters: revenue accelerating
QuarterRevenue
Sep 2023−18.6%
Dec 2023−21.1%
Mar 2024−18.5%
Jun 2024−13%
Sep 2024−2.9%
Dec 20240.3%
Mar 20254.9%
Jun 20258.7%
Sep 202511.7%
Dec 202516.4%
Mar 202617.4%
Jun 202616.5%

Profit, EPS

  • Profit −245.8%
  • EPS −259%
Profit, EPS
QuarterProfitEPS
Sep 2023−39.4%−38.8%
Dec 2023−80.9%−80.8%
Mar 2024−84.7%−84.7%
Jun 2024−92.4%−92.5%
Sep 2024−108%−108.3%
Dec 2024−171.7%−173.9%
Mar 2025−197.6%−201.7%
Jun 2025−245.8%−259%
Sep 2025––
Dec 2025––
Mar 2026––
Jun 2026––
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 2.3%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 20233%
Dec 20232.1%
Mar 20241.6%
Jun 20241.2%
Sep 20242%
Dec 20241.4%
Mar 20251.5%
Jun 20251.4%
Sep 20251.4%
Dec 20251.7%
Mar 20262%
Jun 20262.3%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
FlatRevenue growth · latest +16.5%, range −21.1% to +17.4%
FallingProfit growth · latest −245.8%, range −245.8% to −39.4%
FallingEPS growth · latest −259.0%, range −259.0% to −38.8%
Stuck lowROCE · latest 2.3%, range 1.2% to 3.0%

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+16.4%−2.7%——
Profit—−35.9%——
EPS—−35.8%——
Stock price+24.8%+5.8%−7.8%+20.7%
+11.9%Revenue growth (Jun 2026) · latest quarter against a year ago
−66.3%Profit growth (Jun 2026) · latest quarter against a year ago
2.4%Revenue, 4 years · yearly growth over the long run

How much does Repligen earn on its capital?

Repligen Corporation earned a ROE of 2% in FY25. That is up from a low of −1% in FY24. Its return on capital used (ROIC) is 14.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

It comes from a 6.6% net margin and 0.25× asset turnover (sales divided by assets).

Why the return is what it is (FY25): a 6.6% net margin × 0.25× asset turnover × 1.40× leverage (assets divided by equity) ≈ 2.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: −4.8% − 9.3% = −14.1 percentage points. The 9.3% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

The −4.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 1.8%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

FY25: ROE 2%, the climb back from FY24's −1%

  • ROE 2.3%
  • ROIC (annual) 1.8%
  • Cost of capital 9.3%
FY25: ROE 2%, the climb back from FY24's −1%
QuarterROEROIC (annual)Cost of capital
FY217.3%11.1%9.3%
FY229.7%10.3%9.3%
FY231.8%1.7%9.3%
FY24−1.3%2%9.3%
FY252.3%1.8%9.3%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 9.3% cost of capital used on this page.

Jun 2026: ROIC 2.3% (last 12 months) against a 9.3% cost of capital

  • ROIC (12 months) 2.3%
  • ROE (12 months) 1.6%
  • Cost of capital 9.3%
Jun 2026: ROIC 2.3% (last 12 months) against a 9.3% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20235.9%4%9.3%
Dec 20233%3.4%9.3%
Mar 2024−7.6%−3.3%9.3%
Jun 2024−8.1%0.7%9.3%
Sep 2024−8.6%1.2%9.3%
Dec 2024−7.6%−0.1%9.3%
Mar 20251.7%−6.8%9.3%
Jun 20251.8%1.2%9.3%
Sep 20251.7%2.9%9.3%
Dec 20251.5%2.9%9.3%
Mar 20261.7%2.5%9.3%
Jun 20262.3%1.6%9.3%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Repligen have too much debt?

Repligen Corporation has total debt of $691 M against shareholder equity of $2.1 B as of Jun 2026, so its debt is 0.33× its equity. Year by year, that ratio went from 0.21 in FY21 to 0.33 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $690 M, 0.33× equity

  • Total debt $690 M
FY25: debt $690 M, 0.33× equity
QuarterTotal debt
FY21$366 M
FY22$423 M
FY23$712 M
FY24$686 M
FY25$690 M

Debt-to-equity

  • Debt-to-equity 0.33×
Debt-to-equity
QuarterDebt-to-equity
FY210.21×
FY220.22×
FY230.36×
FY240.35×
FY250.33×
Top: total debt each year, $ M. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $691 M, debt-to-equity 0.33

  • Total debt (quarterly) $691 M
Jun 2026: debt $691 M, debt-to-equity 0.33
QuarterTotal debt (quarterly)
Sep 2023$420 M
Dec 2023$712 M
Mar 2024$738 M
Jun 2024$743 M
Sep 2024$672 M
Dec 2024$686 M
Mar 2025$684 M
Jun 2025$686 M
Sep 2025$689 M
Dec 2025$690 M
Mar 2026$688 M
Jun 2026$691 M

Debt-to-equity

  • Debt-to-equity 0.33×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.21×
Dec 20230.36×
Mar 20240.38×
Jun 20240.37×
Sep 20240.33×
Dec 20240.35×
Mar 20250.34×
Jun 20250.33×
Sep 20250.33×
Dec 20250.33×
Mar 20260.33×
Jun 20260.33×
Top: total debt each quarter, $ M. Below: debt-to-equity, ×. Last 12 quarters.

What is the Repligen shareholding pattern?

11.7% of Repligen Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 5.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

11.7%Short interest · of the tradable float
5.5Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Repligen from balance-sheet trouble?

For Repligen Corporation, the Z-score is 6.92. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 6.92 is well clear of the danger zone, so the balance sheet is not the risk here.

How does Repligen rank in its industry?

46.8 out of 100, rank 15 of 30 in Medical Instruments & Supplies, with 74% of the evidence available.

Repligen Corporation scores 46.8 out of 100 against the 30 companies it is compared with in Medical Instruments & Supplies, ranking 15. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 22.6 + 8.9 + 3.7 + 11.6 = 46.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Repligen compared with?

Repligen ranks 15 of 30 Medical Instruments & Supplies companies on the 4-Factor Sector Score, with 46.8 out of 100.

  1. 1West Pharmaceutical Services, Inc.WST · breaking out · Most evidence points up · 81% evidence67.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.5/35 · Revenue 12.4% · Profit 15.8% · Operating margin change 1.6 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 21.2% · Operating margin 22.5% · 76% evidenceValuation 7.0/20 · P/E 44.9× · PEG 2.65 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 10.3% · Lead over S&P 500 25.3% · 1 year 50.8% · 100% evidence · 5 of 12 weeks aheadExact sum: 23.5 + 20.6 + 7 + 16.5 = 67.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2LeMaitre Vascular, Inc.LMAT · turning · Evidence leans up · 81% evidence63.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.7/35 · Revenue 11.5% · Profit 40.4% · Operating margin change 3.9 points · 83% evidenceCapital efficiency 17.3/25 · ROCE 11.9% · Operating margin 29% · 76% evidenceValuation 14.0/20 · P/E 33.4× · PEG 0.86 · 65% evidenceRelative strength 5.6/20 · Lead over its industry -22.3% · Lead over S&P 500 -11.1% · 1 year 1.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 26.7 + 17.3 + 14 + 5.6 = 63.6 · What this means: Earnings are strong; relative strength in its sector is -22.3% and the one-year return is 1.3%.
  3. 3Intuitive Surgical, Inc.ISRG · breaking out · Evidence leans up · 85% evidence61.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.8/35 · Revenue 20.4% · Profit 7.7% · Operating margin change 3 points · 95% evidenceCapital efficiency 21.4/25 · ROCE 22% · Operating margin 33.3% · 76% evidenceValuation 4.5/20 · P/E 48.6× · PEG 5.33 · 65% evidenceRelative strength 9.1/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.7% · 1 year -13.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 26.8 + 21.4 + 4.5 + 9.1 = 61.8 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  4. 4AtriCure, Inc.ATRC · leader · Evidence leans up · 64% evidence58.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.2/35 · Revenue 14% · Profit — · Operating margin change 10.8 points · 62% evidenceCapital efficiency 6.1/25 · ROCE 2.2% · Operating margin 6.3% · 76% evidenceValuation 8.9/20 · P/E 134.3× · PEG — · 15% evidenceRelative strength 19.6/20 · Lead over its industry 41.7% · Lead over S&P 500 59.4% · 1 year 104.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.2 + 6.1 + 8.9 + 19.6 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5ResMed Inc.RMD · breaking out · Evidence leans up · 81% evidence58.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.8/35 · Revenue 9.8% · Profit 8.8% · Operating margin change -3 points · 83% evidenceCapital efficiency 21.5/25 · ROCE 25.4% · Operating margin 30.9% · 76% evidenceValuation 10.2/20 · P/E 18.5× · PEG 1.91 · 65% evidenceRelative strength 8.5/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.9% · 1 year -4.4% · 100% evidence · 11 of 12 weeks aheadExact sum: 17.8 + 21.5 + 10.2 + 8.5 = 58 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Merit Medical Systems, Inc.MMSI · losing its lead · Evidence leans up · 81% evidence57.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.0/35 · Revenue 10.3% · Profit 22.7% · Operating margin change 2.2 points · 83% evidenceCapital efficiency 14.3/25 · ROCE 8.1% · Operating margin 14.5% · 76% evidenceValuation 12.7/20 · P/E 28.4× · PEG 1.22 · 65% evidenceRelative strength 8.1/20 · Lead over its industry -4.7% · Lead over S&P 500 7.8% · 1 year 3.5% · 100% evidence · 10 of 12 weeks aheadExact sum: 22 + 14.3 + 12.7 + 8.1 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Bausch + Lomb CorporationBLCO · turning · Evidence leans up · 64% evidence56.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.4/35 · Revenue 8.8% · Profit — · Operating margin change 6.8 points · 62% evidenceCapital efficiency 7.2/25 · ROCE 3.4% · Operating margin 7.7% · 76% evidenceValuation 11.5/20 · P/E -18.5× · PEG — · 15% evidenceRelative strength 15.9/20 · Lead over its industry 1.5% · Lead over S&P 500 15.3% · 1 year 32.5% · 100% evidence · 8 of 12 weeks aheadExact sum: 21.4 + 7.2 + 11.5 + 15.9 = 56 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Kestra Medical Technologies, Ltd.KMTS · breaking out · Evidence leans up · 64% evidence54.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 63.6% · Profit — · Operating margin change 27.5 points · 71% evidenceCapital efficiency 3.4/25 · ROCE -48% · Operating margin -121.6% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 16.4/20 · Lead over its industry 4.3% · Lead over S&P 500 18.1% · 1 year 16.3% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.1 + 3.4 + 10 + 16.4 = 54.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Becton, Dickinson and CompanyBDX · leader · Evidence leans up · 71% evidence51.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.2/35 · Revenue 5.8% · Profit -40.6% · Operating margin change -1.4 points · 83% evidenceCapital efficiency 13.6/25 · ROCE 7.6% · Operating margin 15.7% · 76% evidenceValuation 9.6/20 · P/E 44.3× · PEG — · 15% evidenceRelative strength 13.7/20 · Lead over its industry -1.6% · Lead over S&P 500 11.4% · 1 year 17.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 14.2 + 13.6 + 9.6 + 13.7 = 51.1 · What this means: Relative strength against the index is 11.4%, and revenue and profit growth are weak.
  10. 10STAAR Surgical CompanySTAA · turning · Too little evidence to rank firmly · 58% evidence50.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.2/35 · Revenue — · Profit — · Operating margin change -15 points · 45% evidenceCapital efficiency 12.8/25 · ROCE 10.3% · Operating margin 10.9% · 76% evidenceValuation 8.6/20 · P/E 360.4× · PEG — · 15% evidenceRelative strength 10.6/20 · Lead over its industry -6.6% · Lead over S&P 500 6.8% · 1 year 2.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 18.2 + 12.8 + 8.6 + 10.6 = 50.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  11. 11Baxter International Inc.BAX · quiet · Evidence leans down · 64% evidence49.9out of 100GrowthCapitalValuationRelative
  12. 12The Cooper Companies, Inc.COO · basing · Evidence leans down · 85% evidence49.3out of 100GrowthCapitalValuationRelative
  13. 13Solventum CorporationSOLV · turning · Evidence leans down · 71% evidence48.5out of 100GrowthCapitalValuationRelative
  14. 14Avantor, Inc.AVTR · leader · Evidence leans down · 71% evidence48.3out of 100GrowthCapitalValuationRelative
  15. 15Repligen Corporation this pageRGEN · leader · Evidence leans down · 74% evidence46.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.6/35 · Revenue 16.5% · Profit — · Operating margin change 4.8 points · 62% evidenceCapital efficiency 8.9/25 · ROCE 2.3% · Operating margin 9.3% · 76% evidenceValuation 3.7/20 · P/E 185.3× · PEG 8.54 · 65% evidenceRelative strength 11.6/20 · Lead over its industry 0.1% · Lead over S&P 500 13.1% · 1 year 24.8% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.6 + 8.9 + 3.7 + 11.6 = 46.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  16. 16Azenta, Inc.AZTA · leader · Evidence leans down · 64% evidence46.7out of 100GrowthCapitalValuationRelative
  17. 17Alcon Inc.ALC · turning · Evidence leans down · 61% evidence45.1out of 100GrowthCapitalValuationRelative
  18. 18Align Technology, Inc.ALGN · quiet · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  19. 19AptarGroup, Inc.ATR · turning · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  20. 20Envista Holdings CorporationNVST · quiet · Too little evidence to rank firmly · 58% evidence44.4out of 100GrowthCapitalValuationRelative
  21. 21Teleflex IncorporatedTFX · turning · Evidence leans down · 71% evidence43.8out of 100GrowthCapitalValuationRelative
  22. 22Stevanato Group S.p.A.STVN · quiet · Evidence leans down · 81% evidence43.7out of 100GrowthCapitalValuationRelative
  23. 23ICU Medical, Inc.ICUI · quiet · Evidence leans down · 64% evidence38.7out of 100GrowthCapitalValuationRelative
  24. 24Medline Inc.MDLN · turning · Too little evidence to rank firmly · 51% evidence37.3out of 100GrowthCapitalValuationRelative
  25. 25DENTSPLY SIRONA Inc.XRAY · basing · Most evidence points down · 64% evidence31.7out of 100GrowthCapitalValuationRelative
  26. 26Warby Parker Inc.WRBY · quiet · Most evidence points down · 64% evidence28.7out of 100GrowthCapitalValuationRelative
  27. 27BioLife Solutions, Inc.BLFS · Too little evidence to rank firmly · 44% evidence48.0out of 100GrowthCapitalValuationRelative
  28. 28Pulse Biosciences, Inc.PLSE · leader · Too little evidence to rank firmly · 41% evidence44.5out of 100GrowthCapitalValuationRelative
  29. 29MiniMed Group, Inc.MMED · quiet · Too little evidence to rank firmly · 41% evidence39.1out of 100GrowthCapitalValuationRelative
  30. 30Alamar Biosciences, Inc.ALMR · quiet · Too little evidence to rank firmly · 28% evidence38.8out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Instruments & Supplies, all 30 compared on one page.

Which companies are close to Repligen in size?

Repligen is the 11th largest of 38 Medical Instruments & Supplies companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Baxter International Inc., The Cooper Companies, Inc. and Align Technology, Inc. Just below it: Avantor, Inc., AptarGroup, Inc. and Bausch + Lomb Corporation.

Medical Instruments & Supplies companies close in size

  1. Baxter International Inc. $13.7 billion
  2. The Cooper Companies, Inc. $12.2 billion
  3. Align Technology, Inc. $11.7 billion
  4. Repligen Corporation $11.4 billion
  5. Avantor, Inc. $10.6 billion
  6. AptarGroup, Inc. $9.3 billion
  7. Bausch + Lomb Corporation $7.4 billion

All 38 Medical Instruments & Supplies companies, largest first

Companies close in size in other industries

  1. Insulet Corporation $11.4 billion · Medical Devices
  2. Bio-Techne Corporation $11.4 billion · Biotechnology
  3. Repligen Corporation $11.4 billion
  4. Li Auto Inc. $11.4 billion · Auto Manufacturers
  5. Chime Financial, Inc. $11.3 billion · Software - Application

What else do people ask about Repligen?

What were Repligen's latest quarterly results?

Repligen Corporation reported revenue of $204 M and net profit of $5.0 M for the Jun 2026 quarter. Revenue rose 11.9% and profit fell 66.3% compared with a year earlier. Earnings per share were $0.09.

The operating margin was 9.3%, 4.8 percentage points higher than a year earlier (as of 4 November 2026).

What is Repligen's market cap?

Repligen Corporation's market capitalisation is $11.4 B at a stock price of $178.20. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Repligen performing?

Repligen Corporation's share price has been rising for 15 weeks. In its latest quarter, revenue rose 11.9% and profit fell 66.3% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 22 weeks running (as of 4 November 2026).

Will Repligen's stock price go up?

This page does not forecast Repligen Corporation's stock price. What it shows instead: the stock price is $178.20, and it has been rising for 15 weeks. Its P/E of 246.9× is higher than 65% of its own last 5 years (as of 4 November 2026).

Where is Repligen in its business cycle?

Repligen Corporation's FY25 operating margin was 6.2%, against a 5-year range of 5.9% to 25.8%: the low end of its own range, which is often where recoveries start. The latest quarter was 9.3%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Repligen story?

Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Repligen a stock worth studying right now?

What the numbers show: Repligen Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.